Target intelligence / Profile preview

Hemozoin (Hz)

Target
Hz
Molecular classification
Macromolecule, Other
01

Overview

Hemozoin is a dark brown biocrystal synthesized by Plasmodium falciparum and other blood-feeding parasites within their acidic digestive food vacuole. During the intraerythrocytic stage of malaria, the parasite ingests and degrades host hemoglobin to obtain amino acids, a process that releases large amounts of free, redox-active, and highly toxic heme (ferriprotoporphyrin IX). To prevent heme-induced oxidative stress, lipid peroxidation, and cellular lysis, the parasite detoxifies free heme by crystallizing it into insoluble, chemically inert hemozoin. This non-enzymatic biomineralization process is essential for parasite survival and represents a highly validated therapeutic target. Classic antimalarial drugs, such as chloroquine, quinine, and amodiaquine, act by binding to free heme or the growing crystal surface of hemozoin, thereby preventing further crystallization. This leads to a lethal accumulation of toxic free heme and heme-drug complexes within the food vacuole, ultimately killing the parasite. Because hemozoin formation is a physicochemical process unique to the parasite, targeting it offers high selectivity, though resistance has emerged primarily through mutations in vacuolar transporters like PfCRT that efflux the drugs rather than alterations in the crystallization pathway itself.

Other names
Heme/hemozoinMalarial pigmentBeta-hematinβ-hematinHeme crystallization pathwayHeme detoxification pathway
02

Mechanism of action

Inhibition of heme crystallization into hemozoin, leading to the accumulation of toxic free heme (ferriprotoporphyrin IX) which causes oxidative stress, membrane damage, and lysis of the malaria parasite.

03

Biological functions

Heme detoxificationBiomineralizationCrystallizationOther
04

Disease associations

Infection
05

Safety considerations

Drug resistance (mediated by PfCRT mutations)Cardiotoxicity (QT prolongation)RetinopathyNeurotoxicity
06

Interacting drugs

11 more in the full profile.

07

Biomarkers

ParasitemiaHemozoin levelsPlasmodium falciparum histidine-rich protein 2 (PfHRP2)

Beyond the preview

Go deeper on Hemozoin (Hz).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Hemozoin (Hz).

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call